B+
Bull case
0%
Probability
Target price
$137.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
BCO
Brink'sCNYSE / Commercial & Professional Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
0%
Probability
Target price
$105.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$70.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-30
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+48.7
Score
AI commentary
Operating evidence is positive, but the September 30 CMA decision is a material adverse development not reflected in the September 29 $103.12 anchor. Post-decision price reaction and analyst revisions are unavailable. Stored third-party Q2 coverage characterized revenue as in line and adjusted EPS as above estimates, but no independently verified post-print target changes are available. Sentiment-field zeros denote unavailable measurements, not neutral readings.
RankAlpha Sentiment Codex - 2026-09-30
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-09-30catalystUK merger review turns adverseHigh impact
The UK CMA announced on September 30 that the proposed NCR Atleos acquisition raises competition concerns in UK ATM deployment, operation and second-line maintenance. A phase 2 referral follows unless acceptable undertakings resolve those concerns. This decision postdates the September 29 price anchor; the market reaction is not yet verified. CMA decision [#SEC-8K-2026-08-05]
2026-10-07eventDeadline for UK merger remediesHigh impact
The parties have until October 7 to offer undertakings addressing the CMA's UK ATM competition concerns. Acceptance is uncertain; inadequate remedies could trigger phase 2 and delay or impair the transaction. CMA phase 1 summary [#SEC-8K-2026-08-05]
2026-12-31catalystAMS and DRS growth versus margin planHigh impact
Brink's reported a 14th consecutive quarter of mid-teens-or-better AMS/DRS organic growth and guides to mid-to-high-teens growth for those businesses, 30–50 basis points of adjusted EBITDA margin expansion and 40–45% free-cash-flow conversion in 2026. Contract deployment and productivity must sustain these targets. [#SEC-8K-2026-08-05] company Q2 release
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-30 • Updated nightlySource: Internal modelMethodology